Sign in
4

Changes in Ownership

Aldeyra Therapeutics, Inc. Filed Acc 0000904454-19-000466

Options or other derivatives

  • Director acquired 22,367 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Table II: Derivative

Insider Date Transaction Shares Price Value Owned after D/I
TREU JESSE I Director 2019-06-04 Grant or award · Stock Option (right to buy) +18,951 18,951 D: show line 1 in the form
TREU JESSE I Director 2019-06-04 Grant or award · Stock Option (right to buy) +1,763 1,763 D: show line 2 in the form
TREU JESSE I Director 2019-06-04 Grant or award · Stock Option (right to buy) +1,653 1,653 D: show line 3 in the form
Loading xslF345X03/edgar.xml…